Novel Therapeutics in Ovarian Cancer: Expanding the Toolbox. [PDF]
Curr Oncol, 2023 Moufarrij S, O'Cearbhaill RE.
europepmc +1 more source
Homologous Recombination Proficiency in High-Grade Serous Epithelial Ovarian Cancer Tumors: The Dark Side of the Moon. [PDF]
Curr Issues Mol BiolPavanello M +3 more
europepmc +1 more source
Non-invasive tools for analysis of plasma membrane protein topology in living cells. [PDF]
MethodsSavenkova D +4 more
europepmc +1 more source
Exploring the therapeutic use and outcome of antibody-drug conjugates in ovarian cancer treatment. [PDF]
OncogeneNarayana RVL, Gupta R.
europepmc +1 more source
Carcinogenesis Associated with Toxin Nephropathy: Proposed Mediation by Phosphate Toxicity. [PDF]
CellsBrown RB, Mielke JG.
europepmc +1 more source
The clinical development of antibody-drug conjugates for non-small cell lung cancer therapy. [PDF]
Front Immunol, 2023 Liu X +9 more
europepmc +1 more source
Therapeutic Applications and Target Strategies of Antibody-Drug Conjugates in Ovarian Cancer. [PDF]
Iran J Pharm ResLiu Q, Zhou R, He T, Zhao Y, Yang M.
europepmc +1 more source
Understanding the Chemical Characteristics of Payloads and the Expression of Tumor-Associated Antigens of ADCs in Clinical Development. [PDF]
ACS OmegaNieto-Jiménez C +13 more
europepmc +1 more source
Editorial: In celebration of women in science: Lipids, membranes, and membranous organelles. [PDF]
Front Mol Biosci, 2023 López-Lara IM, Govorunova EG.
europepmc +1 more source
Human-specific activation of the DUX4-SLC34A2 axis by herpesviruses suppresses antiviral innate immunity. [PDF]
mBioGao M +10 more
europepmc +1 more source